APA (7th ed.) Citation

Devos, T., Geukens, T., Schauvlieghe, A., Ariën, K. K., Barbezange, C., Cleeren, M., . . . Meyfroidt, G. (2020). A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care in patients hospitalized with COVID-19. Trials, 21(1), 1. https://doi.org/10.1186/s13063-020-04876-0

Chicago Style (17th ed.) Citation

Devos, Timothy, et al. "A Randomized, Multicentre, Open-label Phase II Proof-of-concept Trial Investigating the Clinical Efficacy and Safety of the Addition of Convalescent Plasma to the Standard of Care in Patients Hospitalized with COVID-19." Trials 21, no. 1 (2020): 1. https://doi.org/10.1186/s13063-020-04876-0.

MLA (9th ed.) Citation

Devos, Timothy, et al. "A Randomized, Multicentre, Open-label Phase II Proof-of-concept Trial Investigating the Clinical Efficacy and Safety of the Addition of Convalescent Plasma to the Standard of Care in Patients Hospitalized with COVID-19." Trials, vol. 21, no. 1, 2020, p. 1, https://doi.org/10.1186/s13063-020-04876-0.